Abstract
Refractory ascites is difficult to treat by restriction of salt and repeated paracentesis which have been the mainstay of treating it for a long time. Sapheno-peritoneal shunts have been performed in patients with refractory ascites . Here, we evaluated the use of saphenous vein to be anastomosed to the peritoneam to drain the refractory ascites. Nine patients (7 male, median age 45 years, range 17 - 69) with tense refractory ascites associated with liver cirrhosis, perioprtal fibrosis and end stage renal diseases underwent sapheno-peritoneal anastomosis by mobilizing and rotating the proximal vein in order to be anastomosed to peritoneum in the lower abdomen . All procedures were performed under local anaesthesia. Thirty-day mortality was 22% (2) patient. Morbidity included fluid leakage in 1 (11%), and wound infection in 1 (11%). Hospital stay (median) was 16 days (range 11 to 23). In the short term (median of 2 months) significant reduction in body weight and abdominal girth was seen in 9 (90%), 6 (60%) were not on diuretics while 3 (30%) continued to remain on reduced doses of diuretic. Furthermore, 7 (70%) did not require paracentesis. At 2-year follow-up, 5 (45%) patients died and 3 succumbed during follow-up. The remaining 3 were all in active employment, 1 was off diuretics, and 2 were on reduced doses. All 3 patients maintained reduced body weights and abdominal girths compared with preoperative values. Saphenous-peritoneal shunt appears a simple, safe, and cost effective method of achieving long-term control of refractory ascites. The use of autogenous shunt is an added advantage over prosthetic shunts for drainage of ascitic fluid.
Keywords
Ascites, sapheno-peritoneal shunt, anastomoses, peritoneum, abdomen.
References
Le Veen HH, Christoudias G, Moon IP. Peritoneovenous shunting for ascites. Ann Surg. 1974;180(4):580–590.
Hillaire S, Labianca M, Borgonovo G. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: Improving results and predictive factors of failure. Surgery.1993; 113(4):373–379.
Elcheroth J, Vons C, Franco D. Role of surgical therapy in management of intractable ascites. World J Surg. 1994; 18(2):240–245.
Zervos EE, Rosemurgy AS. Management of medically refractory ascites. Am J Surg.2001; 181(3):256–264.
Lund RH, Newkirk JB. Peritoneovenous shunting system for surgical management of ascites. Contemp Surg. 1979; 14:31–45.
Lund RH, Mortitz MW. Complications of Denver peritoneovenous shunting. Arch Surg.1982; 117(7):924–928.
Valdeyar HJ, Doran DJ, Charnley R, Ryder SD. Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease. Br J Surg.1999; 86(7):882–885.
Petr Utíkal, Petr Dráč, Petr Bachledaa, Jiří Klein. Peritoneosaphenous shunt, modification with the use of long sapheous vein. Biomedial papers. 2004; 148(1):89-90.
Mohamed M.Essawy, Hisham R. El-Khayat.
Evaluation of peritoneovenous Denever shunt in the management of intractable non malignant hepatic ascites. EJS. 2001;20(4):783-794.